It is a pharma public limited company based in Delhi, Delhi, India, established in 2005.
2005 | Delhi, Delhi, India | ActiveEureka Aventis Labs Limited, a active public limited company, was established on 21 October 2005 in Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24232DL2005PLC142039. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.00 M.
It upholds a compliant status. Its leadership includes Manish Kumar Agarwal (Director), Nishant Garg (Director), Ajay Kumar Gupta (Director). Past directors included Nishant Garg, Peeyush Kumar, Prashant Garg. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Gf-02,(Groundfloor),Eurekahouse,A-30/2Westjyotinagar,Shahdara, Delhi, Delhi, 110094.
U24232DL2005PLC142039
142039
21 October 2005
₹2.50 M
₹2.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Eureka Aventis Labs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manish Kumar Agarwal | Director | 21 Oct 2005 | Current |
| Nishant Garg | Director | 15 Apr 2021 | Current |
| Ajay Kumar Gupta | Director | 21 Oct 2005 | Current |
| Ashok Kumar Gupta | Director | 21 Oct 2005 | Current |
| Prashant Garg | Director | 15 Apr 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 11 Nov 2021 | Past |
| Pramod Abcsdd | Director | 22 Apr 2021 | Past |
| Pramod Abcsdd | Additional Director | 11 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Eureka Aventis Labs Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 70.19% decrease in profit. The company's net worth moved up by a moderate rise of 0.64%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Eureka Aventis Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Eureka Aventis Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Eureka Aventis Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eureka Aventis Labs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Eureka Aventis Labs Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Eureka Aventis Labs Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Progress on Nishant Garg was appointed as a Director was appointed as a Director on 15 Apr 2021 & has been associated with this company since 4 years 7 months . was documented.
Prashant Garg was appointed as a Director was appointed as a Director on 15 Apr 2021 & has been associated with this company since 4 years 7 months . was recorded as a recent event.
Manish Kumar Agarwal was appointed as a Director was appointed as a Director on 21 Oct 2005 & has been associated with this company since 20 years 1 month . was recorded as a recent event.
Ajay Kumar Gupta was appointed as a Director was appointed as a Director on 21 Oct 2005 & has been associated with this company since 20 years 1 month . was recorded as a recent event.
The CIN of Eureka Aventis Labs Limited is U24232DL2005PLC142039.
Eureka Aventis Labs Limited is headquartered at Gf-02,(Groundfloor),Eurekahouse,A-30/2Westjyotinagar,Shahdara, Delhi, Delhi, 110094.
Eureka Aventis Labs Limited was incorporated on 21 October 2005.
The current directors of Eureka Aventis Labs Limited are
The primary industry of Eureka Aventis Labs Limited is Pharma.
Eureka Aventis Labs Limited is unlisted.
The authorized capital of Eureka Aventis Labs Limited is ₹2.50 M, and the paid-up capital is ₹2.00 M.
The compliance status of Eureka Aventis Labs Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX